Clinical significance of immunohistochemical expression of hypoxia-inducible factor - 1α as a prognostic marker in rectal adenocarcinoma

Clinical Colorectal Cancer

Volumn 5, Issue 5, 2006, Pages 350-353

  Lu, Xue Guan ^a   Xing, Chun Gen ^a   Feng, Yi Zhong ^a   Chen, Jie ^a   Deng, Chong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Dukes stage; Lymph node metastasis; Prognosis; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; FOLINIC ACID; FORMALDEHYDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXALIPLATIN; PARAFFIN; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 33244457607     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2006.n.005     Document Type: Article

References (26)

1. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998; 48:149-156.
2. Rofstad EK, Sunfor K, Lyng H, et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 2000; 83:354-359.
3. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14:831-838.
4. Norsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation responses in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41:31-39.
5. Sutherland RM, Ausserer WA, Murphy BJ, et al. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol 1996; 6:59-70.
6. Blancher C, Harris AL. The molecular basis of the hypoxia response pathway: tumor hypoxia as a therapy target. Cancer Metastasis Rev 1998; 17:187-194.
7. Wenger RH. Mammalian oxygen sensing, signaling and gene regulation. J Exp Biol 2000; 203:1253-1263.
8. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92:5510-5514.
9. Huang LE, Arany Z, Livingston DM, et al. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J Biol Chem 1996; 271:32253-32259.
10. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002; 64:993-998.
11. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Ann Rev Cell Dev Biol 1999; 15:551-578.
12. Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996; 271:17771-17778.
13. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 1999; 59:5830-5835.
14. Bos R, van der Groep P, Greijer AE, et al. Levels of hypoxia-inducible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97:1573-1581.
15. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61:2911-2916.
16. Theodoropoulos VE, Lazaris AC, Sofras F, et al. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 2004; 46:200-208.
17. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997; 38:285-289.
18. Fyles A, Milosevic M, Hedley D, et al. Tumor hypoxia has independebt predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002; 20:680-687.
19. Milosevic M, Fyles A, Hedley D, et al. The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. Semin Radiat Oncol 2004; 14:249-258.
20. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12:5447-5454.
21. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumors and survival. Br J Cancer 2001; 85:881-890.
22. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-inducible factor (HIF-1A and HIF-2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53:1192-1202.
23. Kimura S, Kitadai Y, Kuwai T, et al. Expression of hypoxia-inducible factor (HIF)-1 alpha is associated with vascular endothelial growth factor expression and tumor angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40:1904-1912.
24. Gray MJ, Zhang J, Ellis LE, et al. HIF-1α, STAT3, CBP/p300 and Ref-1/ APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005; 24:3110-3120.
25. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Moll Cell Biol 1996; 16:4604-4613.
26. Griffiths L, Dachs GU, Bicknell R, et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast-tumor cells grown in vitro and in vivo. Cancer Res 1997; 57:570-572.